Advertisement
Hong Kong stock market
BusinessChina Business

Hong Kong stocks complete sixth week of gains on upbeat China outlook

Jiangsu Hengrui’s strong Hong Kong debut boosts Chinese pharmaceutical stocks

Reading Time:2 minutes
Why you can trust SCMP
2
Hong Kong stocks have rallied strongly over the last six weeks. Photo: Edmond So
Zhang Shidongin Shanghai
Hong Kong stocks capped a sixth straight weekly gain on optimism that a de-escalation in US-China tensions will dispel the gloom surrounding China’s growth outlook, alongside last month’s data pointing to a mild ongoing recovery.

The Hang Seng Index closed 0.2 per cent higher at 23,601.26. The benchmark added 1.1 per cent this week, the longest winning stretch in three months. The Hang Seng Tech Index slipped 0.1 per cent. On the mainland, the CSI 300 Index dropped 0.8 per cent and the Shanghai Composite Index finished 0.9 per cent lower.

Chinese pharmaceutical stocks got a boost from Jiangsu Hengrui Pharmaceuticals’ strong debut in Hong Kong on Friday. The nation’s biggest drug maker by market capitalisation surged by as much as 37 per cent. CSPC Pharmaceutical Group rallied 2.2 per cent to HK$6.62 and Wuxi AppTec advanced 0.8 per cent to HK$67.65. BYD climbed 2 per cent to a record HK$465.20 after its electric vehicle sales in Europe surpassed Tesla’s for the first time in April. Peer Li Auto advanced 1.1 per cent to HK$113.50.
Advertisement

“Recent economic data showed that external demand remains strong and domestic demand is recovering but mildly,” said Wang Jun, an analyst at BOC International. “The risk of downside to economic growth is low, as China has plenty of room for policy measures. But a further breakout of the market depends on the strength of the economic recovery.”

Sun Piaoyang, chairman of Hengrui, strikes the gong to commence the company’s trading on the Hong Kong stock exchange on Friday. Photo: Aileen Chuang
Sun Piaoyang, chairman of Hengrui, strikes the gong to commence the company’s trading on the Hong Kong stock exchange on Friday. Photo: Aileen Chuang

Investors brushed aside Moody’s downgrade of the US government’s credit rating this week to focus on the implications of the 90-day tariff truce between the US and China, and the first set of post-tariff data from the Asian nation. The mixed data showed that industrial production and exports remained resilient despite the US levies of as much as 145 per cent, while retail sales and fixed-asset investments lagged.

Advertisement
Advertisement
Select Voice
Choose your listening speed
Get through articles 2x faster
1.25x
250 WPM
Slow
Average
Fast
1.25x